Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Salvati Mark E is active.

Publication


Featured researches published by Salvati Mark E.


Archive | 2008

EXTENDED AMINO CETP INHIBITORS

Salvati Mark E; Johnson James A; Xu Ningning


Archive | 2016

ΟΜΟ- ΚΑΙ ΕΤΕΡΟΚΥΚΛΙΚΕΣ ΕΝΩΣΕΙΣ ΚΑΤΑΛΛΗΛΕΣ ΩΣ CETP ΑΝΑΣΤΟΛΕΙΣ

Salvati Mark E; Finlay Heather; Chen Bang-Chi; Harikrishnan Lalgudi S; Jiang Ji; Johnson James A; Kamau Muthoni G; Lawrence Michael R; Li Jianqing; Lloyd John; Miller Michael Matthew; Pi Zulan; Qiao Jennifer X; Rampulla Richard; Wang Tammy C; Wang Yufeng; Yang Wu; Roberge Jacques Y


Archive | 2013

PROCESS FOR PREPARATION OF FLUORINATED PHENOLS

Salvati Mark E; Finlay Heather; Chen Bang-Chi; Harikrishnan Lalgudi S; Jiang Ji; Johnson James A; Kamau Muthoni G; Lawrence Michael R; Li Jianqing; Lloyd John; Miller Michael Matthew; Pi Zulan; Qiao Jennifer X; Rampulla Richard; Wang Tammy C; Wang Yufeng; Yang Wu; Roberge Jacques Y


Archive | 2012

Derivados de N-((3-bencil)-2,2-(bis-fenil-)-propan-1-amina como inhibidores de CETP para el tratamiento de aterosclerosis y enfermedades cardiovasculares

Salvati Mark E; Johnson James A; Xu Ningning


Archive | 2012

COMPUESTOS HOMO- Y HETEROCICLICOS ADECUADOS COMO INHIBIDORES DE LA PTEC.

Salvati Mark E; Finlay Heather; Chen Bang-Chi; Harikrishnan Lalgudi S; Jiang Ji; Johnson James A; Kamau Muthoni G; Lawrence Michael R; Li Jianqing; Lloyd John; Miller Michael Matthew; Pi Zulan; Qiao Jennifer X; Rampulla Richard; Wang Tammy C; Wang Yufeng; Yang Wu; Roberge Jacques Y


Archive | 2012

N-((3-BENZYL)-2,2-(BIS-PHENYL)-PROPAN-1- AMINDERIVATE ALS CETP-HEMMER FÜR DIE BEHANDLUNG VON ATHEROSKLEROSE UND HERZ-KREISLAUF- ERKRANKUNGEN

Salvati Mark E; Johnson James A; Xu Ningning


Archive | 2012

Inhibidores heterocíclicos de CETP

Salvati Mark E; Finlay Heather; Harikrishnan Lalgudi S; Jiang Ji; Johnson James A; Kamau Muthoni G; Lawrence R Michael; Miller Michael M; Qiao Jennifer X; Wang Tammy C; Wang Yufeng; Yang Wu


Archive | 2012

Homo- og heterocykliske forbindelser, der er egnede som CETP-inhibitorer

Salvati Mark E; Finlay Heather; Chen Bang-Chi; Harikrishnan Lalgudi S; Jiang Ji; Johnson James A; Kamau Muthoni G; Lawrence Michael R; Li Jianqing; Lloyd John; Miller Michael Matthew; Pi Zulan; Qiao Jennifer X; Rampulla Richard; Wang Tammy C; Wang Yufeng; Yang Wu; Roberge Jacques Y


Archive | 2011

PYRROLOPYRIDAZIN-VERBINDUNGEN UND VERWENDUNGSVERFAHREN DAFÜR ZUR BEHANDLUNG VON PROLIFERATIVEN ERKRANKUNGEN

Salvati Mark E; Barbosa Stephanie A; Chen Zhong; Hunt John T


Archive | 2011

compostos inibidores de cetp, usos do referido compostos e composições farmacêuticas que os contém

Salvati Mark E; Finlay Healther; Chen Bang-Chi; Harikrishnan Lalgudi S; Jiang Ji; Johnson James A; Kamau Muthoni G; Lawrence Michael R; Li Jianqing; Lloyd John; Miller Michael Matthew; Pi Zulan; Qiao Jenniger X; Rampulla Richard; Wang Tammy C; Wang Yufeng; Yang Wu; Roberge Jacques Y

Collaboration


Dive into the Salvati Mark E's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jiang Ji

Bristol-Myers Squibb

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge